Exerts anti-cancer and detoxification effects by indirectly inhibiting TCDD-induced binding of AhR and ARNT to enhancer regions of CYP1A1 and CYP1B1 genes, thereby suppressing RNA polymerase II binding at promoter regions (Beedanagari et al., 2009). The gene discussed is CYP1A1; the disease is cancer.